Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ICICI Lombard General Insurance Company - Q1FY22 Update - ICICI Direct

Posted On: 2021-07-25 07:22:04 (Time Zone: UTC)


Cyclical recovery remains delayed; focus on health is a long term positive

Delay in cyclical recovery of non-life insurance is an industry issue, which is also affecting ICICI Lombard's (ICICIGI) earnings in FY22E, exacerbated by the higher health claims due to covid. The components driving this cyclical trough are: 1) weakness in fresh motor demand, 2) absence of motor TP price hike for the second consecutive year, 3) continued competitive pricing in motor OD, and 4) impact of covid. While lower non-covid health claims and lower motor claims gave respite in FY21, both have almost retraced to pre-covid levels now. However, the structural under-penetration remains a long-term investment thesis and ICICIGI remains well placed to benefit from it. Recommend HOLD (earlier: Add) with a revised target price of Rs1,530 (40x FY23E EPS of ~Rs38).

- Rs1.5bn PAT in Q1FY22 was a negative surprise due to >150% loss ratio in health segment. The negative impact of covid-related claims was Rs6bn (split between actual claims of Rs3.84bn and reserve for likely unreported claims of Rs2.18bn). There were positive benefits marginally through lower motor and non-covid claims at Rs600mn. Hence, the net negative impact in Q1FY22 was Rs5.4bn. Investment income rose 28% QoQ to Rs7bn. We estimate Rs17.4bn PAT in FY23E on the back of: 1) the 17.6% / 3.8% NEP growth in FY22E / FY23E, 2) 79.7% / 73.5% loss ratio in FY22/FY23E, 3) 28.8% / 26.7% opex ratio (commission plus expenses) in FY22E / FY23E, and 4) Rs25.2bn / Rs27bn investment income in FY22E / FY23E.

- Strong execution & robust balance sheet remains long-term tailwinds; time to fruition however appears longer. ICICIGI has increased the number of agents from 35,729 in FY19 to 59,545 in FY21 and 61,385 in Q1FY22. This increase is more towards retail health and in tiers-3&4 cities. It has also increased its virtual offices from 135 in FY18 to 840 in Q1FY22. The ILTakeCare app has seen >700k downloads till Q1FY22, of which >200k happened in Q1FY22. Company has also embarked on inorganic growth with the acquisition of Bharti Axa, which had 1.6% GDPI market share in FY21. It acquired AutoNinja (CRM software for auto dealers) in Nov'19, which has helped renewal rate in motor insurance. Balance sheet remains strong with solvency of 2.76x as of Q1FY22 and an AUM (including fair value change amount) of Rs321bn (equity exposure was at ~11.9% in Q1FY22, up from 9.8% in Q1FY21, 10.2% in H1FY21, 10.9% in 9MFY21).

- Clear focus on health as a priority segment can potentially rerate the stock in long run. Higher agent addition (1,000 in Q1FY22) in health, ~9,400-strong hospital network, and the initiative to establish direct connectivity with customers through ILTakeCare app are steps towards strengthening the health franchise. While inorganic acquisition of a health player could be a lost opportunity (already acquired Bharti Axa), organic initiatives are expected to bear fruit given the track record of ICICIGI.

Shares of ICICI Lombard General Insurance Company Ltd was last trading in BSE at Rs. 1491 as compared to the previous close of Rs. 1543.95. The total number of shares traded during the day was 43772 in over 5369 trades.

The stock hit an intraday high of Rs. 1516.15 and intraday low of 1469. The net turnover during the day was Rs. 65220493.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Automobile Sector - Monthly Quick View - Aug'21 - Mixed Performance across Segments - Reliance Securities

Axis Securities initiating coverage on ICICI Securities

Company Update - Minda Corporation - Q1FY22 - ICICI Direct

Quant Pick - PVR Ltd - ICICI Direct

Quant Pick - ONGC - ICICI Direct

Peak in the headline wholesale inflation is behind us - WPI August 2021 - Acuité Ratings

Sansera Engineering - IPO - Strong Outlook with Steady Cash Flow - Reliance Securities

APL Apollo Tubes - Journey from a semi-commodity player to a branded one - HDFC Securities

Nazara Technologies Ltd - Upbeat in medium-term, Uncertain over Long-term - YES Securities

IPO Review - Sansera Engineering Ltd - ICICI Direct

Overall index is still 0.3% lower than the pre-pandemic levels - IIP July 2021

YES SECURITIES on Monthly General Insurance & Mutual Funds Data

India urban logistics spaces expected to cross 7 million sq. ft by 2022: JLL

Neogen Chemicals - Breaking into the next orbit with a bang - HDFC Securities

Gladiator Stocks - Bharti Airtel Ltd - ICICI Direct

Gladiator Stocks - V-Guard - ICICI Direct

Balkrishna Industries - Industry export growth accelerates - ICICI Securities

HDFC Life Insurance - Exide Life Acquisition - Maintain ADD - YES Securities

Gladiator Stocks - Grindwell Norton - ICICI Direct

Gladiator Stocks - Godrej Properties - ICICI Direct

Monthly Auto Volumes - August 2021 - ICICI Direct

Stock Tales - Easy Trip Planners - ICICI Direct

IPO Review - Vijaya Diagnostic Centre Ltd - ICICI Direct

AU Small Finance Bank - Attrition at top level remains key challenge; business momentum sustained in Jul/Aug'21 - ICICI Securities

Gladiator Stocks - State Bank of India - ICICI Direct

Gladiator Stocks - PNC Infratech - ICICI Direct

Vijaya Diagnostic Centre Ltd - IPO Note - YES Securities

Consumer Durables Sector - Lockdown mars performance yet again - Institutional Research Desk at HDFC Securities

75% of the employees today want to be in office at least once a week as compared to 52% in October 2020: JLL

Gladiator Stocks - Safari Industries - ICICI Direct

Gladiator Stocks - Interglobe Aviation - ICICI Direct

IPO Review - Ami Organics Ltd - ICICI Direct

Q1FY22 GDP - 31st Aug 2021 - Acuité Ratings & Research

Avanti Feeds - Higher input prices hurt margins - ICICI Securities

Company Update - Restructuring - Aarti Industries - ICICI Direct

Q1FY22 Company Update - MM Forgings - ICICI Direct

Company Update - Arvind Fashions - ICICI Direct

Zomato - Can margins and multiples surprise? - ICICI Securities

Ujjivan Small Finance Bank - Top management change and lumpy provisioning concern to weigh on valuation in near term - ICICI Securities

Bharat Dynamics - Guided missile systems to drive orderbook and profit growth - ICICI Securities

Economy - Continued accommodation necessary despite inflationary risks: MPC minutes - ICICI Securities

InterGlobe Aviation - Annual report analysis: Liquidity management remains the mainstay in anticipation of traffic recovery - ICICI Securities

General insurance - Health remains dominant growth driver; Strong all-round performance by Bajaj Allianz - ICICI Securities

Earnings Wrap Q1FY22: Resilient earnings, limited impact of second Covid wave - ICICI Direct

Fine Organic Industries Results Review - In-line performance - HDFC Securities

Power Plus Sector Update - July witnessed strong ~10% generation growth - HDFC Securities

Information Technology Sector Update - 'Hit Refresh' - HDFC Securities

Maintain ADD on JK Cement - Healthy performance - HDFC Securities

Maintain BUY on Star Cement - Margin recovers on pricing gain - HDFC Securities

Maintain BUY on Sadbhav Engineering - Long road to recovery - HDFC Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020